NCT01242813View on ClinicalTrials.gov

Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
TNF-receptor Associated Periodic Syndromes (TRAPS)
Interventions
DRUG

ACZ885

Trial Locations (6)

16147

Novartis Investigative Site, Genova

25123

Novartis Investigative Site, Brescia

27100

Novartis Investigative Site, Pavia

92019

Novartis Investigative Site, Sciacca

Unknown

Novartis Investigative Site, Galway

NW3 2QG

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY